VIEWPOINTS

PharmShots Interview: In Conversation with Nancy Holekamp, Director of Retina Services, Where she Shares Insights on The Results of the Global Survey to Find the Impact of Geographic Atrophy

Shots: Nancy spoke about the results from the Geographic Atrophy Insights Survey (GAINS) Nancy also talked about the emotional burden on the patients and the devastating impact on independence caused by vision loss The global survey was conducted by The Harris Poll on behalf of Apellis Pharmaceuticals to find the impact of GA which is a…

July 6, 2022

PharmShots Interview: In Conversation with Biogen’s Vice President, Monica Mann, Where she Shares Insights on The Publication of Data from the NOVA Study to Treat Multiple Sclerosis

Shots: Monica spoke about the data from the NOVA P-IIIb study evaluating the efficacy of its lead candidate in Multiple Sclerosis(MS) Monica also talked about the clinical trial results and formulation of the advanced product in MS The interview gives a view of Biogen’s developing molecules in the pipeline for MS Smriti: Can you share with…

July 5, 2022

PharmaShots Interview: In Conversation with Caris Life Sciences’, CBO, Brian Lamon, Where he Shares Insights on Opening of New Liquid Biopsy Laboratory Facility

Shots: Brian spoke about opening of its new liquid biopsy lab in Phoenix, AZ and an investment of $45M for the development of its facilities Brian also talked about the establishment of lab will enhance company’s molecular profiling capabilities and launch of a blood-based diagnostic assay The interview gives a view of how Caris Life…

July 4, 2022

PharmaShots Interview: In Conversation with ViiV Healthcare’s Sr. VP, Kimberly Smith, Where she Shares Insights on the US FDA Approval for Label Update of its Lead Candidate in HIV

Shots: Kimberly talked about the approval for label update of ViiV’s lead candidate in HIV, and how an optional oral lead-in will be efficient for people receiving it Kimberly also spoke about ViiV’s collaboration with Janssen for the commercialization of the product The interview gives an understanding of the different treatment options for HIV and…

June 29, 2022

PharmaShots Interview: In Conversation with IO Biotech’s CEO, Mai-Britt Zocca, Where she Shares Insights on the New Data from Metastatic Melanoma Trial Presented at AACR 2022

Shots Mai-Britt talked about the P-I/II clinical trial data and study design of its lead candidate in metastatic melanoma in an e-poster presentation at AACR 2022 She also spoke about IO Biotech’s unique platform with tumor defense mechanisms to kill cancer cells The interview gives a profound understanding of how IO Biotech is advancing to…

June 28, 2022

PharmaShots Interview: In Conversation with Four Prominent Leaders* from Eisai Where they Share Insights on New Alzheimer’s Data Presented at the Alzheimer’s & Parkinson’s Disease Conference

Shots: The interview provided an understanding of the data from its Alzheimer’s disease pipeline at the AD/PD Conference The spokespeople also talked about the clinical trial data and key mechanisms of Eisai’s anti-amyloid compound in AD The discussion showed gave a gist of four key symposium presentations that showed how its lead candidate has the…

June 27, 2022

PharmaShots Interview: In Conversation with SOTIO’s CMO, Richard Sachse, Where he Shares Insights on New Interim Data presented in an Oral Presentation at AACR 2022 Annual Meeting

Shots: Richard spoke about the results from the Phase 1 AURELIO-03 study of IL-15 superagonist Richard also emphasized the clinical benefits of the IL-15 superagonist when combined with pembrolizumab The interview gives a profound understanding of the existing & developing cancer therapies as treatment options for solid tumors Smriti: Explain the details (MOA, ROA, formulations, etc.)…

June 22, 2022

PharmaShots Interview: In Conversation with Cecelia’s CMO, Arnold Saperstein, Where he Shares Insights on Improving Outcomes for Children and Adolescents Living With Type 1 Diabetes (T1D)

Shots: Arnold spoke about Cecelia Health’s collaboration with the UBMD Paediatrics for a clinical study to improve health outcomes for children and adolescents living with T1D Arnold also gave his views on how telehealth options can support the unmet needs of patients with T1D The interview provides a gist of the challenges of living with…

June 20, 2022

PharmaShots Interview: In Conversation with Leonard A. Farber and James Welsh, Where they Share Insights on How Nanoparticle can Trigger an Immune Priming Effect

Shots: Leonard spoke about the newly developed radiotherapy-activated nanoparticle and other cancer therapies developing in Nanobiotix’s pipeline James shared his views on the data presented at the 2022 Annual Meeting of the American Association of Cancer Research The interview provides a core understanding of Nanobiotix’s outlook to expand the utility of nanoparticles in cancer treatment…

June 15, 2022

PharmaShots Interview: In Conversation with Portage’s CEO and Director, Dr. Ian Walters, Where he Shares Insights on Ongoing Clinical-Stage and Development Programs

Shots: Ian spoke about the study design of the clinical trials of its lead iNKT agonists He also emphasized the advancement of novel immunotherapies through new collaborations The interview provides a gist of Portage's development plan for its pipeline and various options to improve cancer treatment Smriti: Explain the details (MOA, ROA, formulations, etc.) of PORT-2 & PORT-3?…

June 8, 2022